FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Guillaume Charpentier

Research Profile

Disorders

Geographic Areas

France

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Chemicals & Drugs

Procedures

Physiology

Living Beings

European Continental Ancestry Group

Concepts & Ideas

Co-author Network

Publications

TOP 3
A Bonnefond; Guillaume Charpentier; Sébastien Czernichow; Aurélie Dechaume; I Ezzidi; philippe froguel; Anette P Gjesing; Samy HADJADJ; Torben Hansen; Serge Hercberg; O Lantieri; Michel Marre; Oluf Pedersen; Julien Philippe; Emmanuel Vaillant; E A Andersson; Beverley Balkau; L Yengo; Martine Vaxillaire
Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes.
Amélie Bonnefond; Guillaume Charpentier; Aurélie Dechaume; Julia S El-Sayed Moustafa; philippe froguel; Niels Grarup; Samy HADJADJ; Torben Hansen; Serge Hercberg; Olivier Lantieri; Torsten Lauritzen; Michel Marre; Ndeye Coumba Ndiaye; Mohsen Azimi Nezhad; Oluf Pedersen; Ronan Roussel; Pierre-Jean Saulnier; Maria G Stathopoulou; Beverley Balkau; Sophie Visvikis-Siest
What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
Jean-Pierre Riveline; Claude Sachon; Pauline Schaepelynck; Agnès Sola-Gazagnes; Véronique Sulmont; Charles Thivolet; Nadia Tubiana-Rufi; Pierre-Yves Benhamou; Bogdan Catargi; Lucy Chaillous; Guillaume Charpentier; Bruno Guerci; Hélène Hanaire; Anne-Marie Leguerrier; Céline Lukas; Luc Millot; François Moreau; Alfred Penfornis; Régis P Radermecker; Eric Renard
Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Guillaume Charpentier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A Bonnefond; Guillaume Charpentier; Sébastien Czernichow; Aurélie Dechaume; I Ezzidi; philippe froguel; Anette P Gjesing; Samy HADJADJ; Torben Hansen; Serge Hercberg; O Lantieri; Michel Marre; Oluf Pedersen; Julien Philippe; Emmanuel Vaillant; E A Andersson; Beverley Balkau; L Yengo; Martine Vaxillaire
Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes.
Diabetologia 2013;56(3):492-6.
2013: Amélie Bonnefond; Guillaume Charpentier; Aurélie Dechaume; Julia S El-Sayed Moustafa; philippe froguel; Niels Grarup; Samy HADJADJ; Torben Hansen; Serge Hercberg; Olivier Lantieri; Torsten Lauritzen; Michel Marre; Ndeye Coumba Ndiaye; Mohsen Azimi Nezhad; Oluf Pedersen; Ronan Roussel; Pierre-Jean Saulnier; Maria G Stathopoulou; Beverley Balkau; Sophie Visvikis-Siest
What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
PloS one 2013;8(2):e55921.
2012: Jean-Pierre Riveline; Claude Sachon; Pauline Schaepelynck; Agnès Sola-Gazagnes; Véronique Sulmont; Charles Thivolet; Nadia Tubiana-Rufi; Pierre-Yves Benhamou; Bogdan Catargi; Lucy Chaillous; Guillaume Charpentier; Bruno Guerci; Hélène Hanaire; Anne-Marie Leguerrier; Céline Lukas; Luc Millot; François Moreau; Alfred Penfornis; Régis P Radermecker; Eric Renard
Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study.
Diabetes care 2012;35(5):965-71.
2012: Amélie Bonnefond; Nabila Bouatia-Naji; Guillaume Charpentier; Nathalie Clément; Sébastien Czernichow; Aurélie Dechaume; Christian Dina; Katherine Fawcett; Beverley Balkau; Inês Barroso; Jean-Luc Guillaume; Samy HADJADJ; Serge Hercberg; Ralf JOckers; Claudia Langenberg; Olivier Lantieri; Michel Marre; Mark I McCarthy; Felicity Payne; Ghislain Rocheleau; Ronan Roussel; Robert Sladek; Emmanuel Vaillant; Martine Vaxillaire; Nicholas J Wareham; Loïc Yengo; philippe froguel
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.
Nature genetics 2012;44(3):297-301.
2012: Jean-Pierre Riveline; Elise Rousseau; Guillaume Charpentier; Aurélie Dechaume; Sabrina Fetita; philippe froguel; Jean-François Gautier; Agnès Hartemann; Catherine Petit; Julien Philippe; Michel Polak; Yves Reznik; Martine Vaxillaire
Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations.
Diabetes care 2012;35(2):248-51.
2012: Marcel Marquez; Michel Marre; Andrew P Morris; François Pattou; Richard D Pearson; John R B Perry; Odile Poulain-Godefroy; Lars Sjöström; Sidonie Vivequin; Andrew J Walley; Loïc Yengo; Beverley Balkau; Lena M S Carlsson; Stéphane Cauchi; Guillaume Charpentier; Mario Falchi; philippe froguel; Stefan Gaget; Barbara Heude; Marlène Huyvaert; Peter Jacobson; Olivier Lantieri; Stéphane Lobbens
Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk.
Diabetes 2012;61(2):524-30.
2010: Sylvia Franc; Dured Dardari; Caroline Peschard; Jean-Pierre Riveline; Magdalena Biedzinski; Beatrix Boucherie; Catherine Petit; Elisabeth Requeda; Frederic Mistretta; Michel Varroud-Vial; Guillaume Charpentier
Can postprandial blood glucose excursion be predicted in type 2 diabetes?
Diabetes care 2010;33(9):1913-8.
2009: Amélie Bonnefond; Martine Vaxillaire; Yann Labrune; Cécile Lecoeur; Jean-Claude Chèvre; Nabila Bouatia-Naji; Stéphane Cauchi; Beverley Balkau; Michel Marre; Jean Tichet; Jean-Pierre Riveline; Samy HADJADJ; Yves Gallois; Sébastien Czernichow; Serge Hercberg; Marika Kaakinen; Susanne Wiesner; Guillaume Charpentier; Claire Lévy-Marchal; Paul Elliott; Marjo-Riitta Jarvelin; Fritz Horber; Christian Dina; Oluf Pedersen; Robert Sladek; David Meyre; philippe froguel
Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.
Diabetes 2009;58(11):2687-97.
2009: Hélène Choquet; Christine Cavalcanti-Proença; Cécile Lecoeur; Christian Dina; Stéphane Cauchi; Martine Vaxillaire; Samy HADJADJ; Fritz F Horber; Natascha Potoczna; Guillaume Charpentier; Juan Ruiz; Serge Hercberg; Suliya Maimaitiming; Ronan Roussel; Michael Boenhnke; Anne U Jackson; Wolfgang Patsch; Franz Krempler; Benjamin F Voight; David Altshuler; Leif Groop; Gudmar Thorleifsson; Valgerdur Steinthorsdottir; Kari Stefansson; Beverley Balkau; philippe froguel; David Meyre
The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects.
Human molecular genetics 2009;18(13):2495-501.
2009: Thomas Sparsø; Amélie Bonnefond; Ehm Andersson; Nabila Bouatia-Naji; Johan Holmkvist; Lise Wegner; Niels Grarup; Anette P Gjesing; Karina Banasik; Christine Cavalcanti-Proença; Marion Marchand; Martine Vaxillaire; Guillaume Charpentier; Marjo-Riitta Jarvelin; Jean Tichet; Beverley Balkau; Michel Marre; Claire Lévy-Marchal; Kristine Faerch; Knut Borch-Johnsen; Torben Jørgensen; Sten Madsbad; Pernille Poulsen; Allan Vaag; Christian Dina; Torben Hansen; Oluf Pedersen; philippe froguel
G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans.
Diabetes 2009;58(6):1450-6.
2009: Konsta Duesing; Guillaume Charpentier; Michel Marre; Jean Tichet; Serge Hercberg; Beverley Balkau; philippe froguel; Fernando Gibson
Evaluating the association of common APOA2 variants with type 2 diabetes.
BMC medical genetics 2009;10():13.
2008: Konsta Duesing; Ghazaleh Fatemifar; Guillaume Charpentier; Michel Marre; Jean Tichet; Serge Hercberg; Beverley Balkau; philippe froguel; Fernando Gibson
Evaluation of the association of IGF2BP2 variants with type 2 diabetes in French Caucasians.
Diabetes 2008;57(7):1992-6.
2008: Andrei I Tarasov; Tamara J Nicolson; Jean-Pierre Riveline; Tarvinder K Taneja; Stephen A Baldwin; Jocelyn M Baldwin; Guillaume Charpentier; Jean-François Gautier; philippe froguel; Martine Vaxillaire; Guy A Rutter
A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
Diabetes 2008;57(6):1595-604.
2008: K Duesing; G Fatemifar; Guillaume Charpentier; M Marre; Jean Tichet; S Hercberg; Beverley Balkau; philippe froguel; F Gibson
Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids.
Diabetologia 2008;51(5):821-6.
2008: Stéphane Cauchi; Hélène Choquet; Ruth Gutiérrez-Aguilar; Frédéric Capel; Katrine Grau; Christine Proença; Christian Dina; Alex Duval; Beverley Balkau; Michel Marre; Natascha Potoczna; Dominique Langin; Fritz Horber; Thorkild I A Sørensen; Guillaume Charpentier; David Meyre; philippe froguel
Effects of TCF7L2 polymorphisms on obesity in European populations.
Obesity (Silver Spring, Md.) 2008;16(2):476-82.
2008: Emmanuelle Durand; Cécile Lecoeur; Jérôme Delplanque; Michael Benzinou; Franck Degraeve; Philippe Boutin; Michel Marre; Beverley Balkau; Guillaume Charpentier; philippe froguel; David Meyre
Evaluating the association of FAAH common gene variation with childhood, adult severe obesity and type 2 diabetes in the French population.
Obesity facts 2008;1(6):305-9.
2008: Stéphane Cauchi; David Meyre; Emmanuelle Durand; Christine Proença; Michel Marre; Samy HADJADJ; Hélène Choquet; Franck De Graeve; Stefan Gaget; Frederic Allegaert; Jérôme Delplanque; Marshall Alan Permutt; Jon Wasson; Ilana Blech; Guillaume Charpentier; Beverley Balkau; Anne-Claire Vergnaud; Sebastien czernichow; Wolfgang Patsch; Mohamed Chikri; Benjamin Glaser; Robert Sladek; philippe froguel
Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.
PloS one 2008;3(5):e2031.
2008: Konsta Duesing; Guillaume Charpentier; Michel Marre; Jean Tichet; Serge Hercberg; Beverley Balkau; philippe froguel; Fernando Gibson
Evaluating the association of common PBX1 variants with type 2 diabetes.
BMC medical genetics 2008;9():14.
2008: K Duesing; Guillaume Charpentier; M Marre; Jean Tichet; S Hercberg; philippe froguel; F Gibson
Evaluating the association of common LMNA variants with type 2 diabetes and quantitative metabolic phenotypes in French Europids.
Diabetologia 2008;51(1):76-81.
2008: Martine Vaxillaire; Jacques Veslot; Christian Dina; Christine Proença; Stéphane Cauchi; Guillaume Charpentier; Jean Tichet; Frédéric Fumeron; Michel Marre; David Meyre; Beverley Balkau; philippe froguel
Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study.
Diabetes 2008;57(1):244-54.
2007: R Gutierrez-Aguilar; Yamina Benmezroua; Beverley Balkau; M Marre; N Helbecque; Guillaume Charpentier; C Polychronakos; Robert Sladek; philippe froguel; Bernadette Neve
Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes.
Diabetes & metabolism 2007;33(5):372-8.
2007: Robert Sladek; Ghislain Rocheleau; Johan Rung; Christian Dina; Lishuang Shen; david serre; Philippe Boutin; Daniel Vincent; Alexandre Belisle; Samy HADJADJ; Beverley Balkau; Barbara Heude; Guillaume Charpentier; Thomas J Hudson; Alexandre Montpetit; Alexey V Pshezhetsky; Marc Prentki; Barry Posner; David J Balding; David Meyre; Constantin Polychronakos; philippe froguel
A genome-wide association study identifies novel risk loci for type 2 diabetes.
Nature 2007;445(7130):881-5.
2007: Ruth Gutiérrez-Aguilar; Yamina Benmezroua; Emmanuel Vaillant; Beverley Balkau; Michel Marre; Guillaume Charpentier; Robert Sladek; philippe froguel; Bernadette Neve
Analysis of KLF transcription factor family gene variants in type 2 diabetes.
BMC medical genetics 2007;8():53.
2007: Nabila Bouatia-Naji; Vincent Vatin; Cécile Lecoeur; Barbara Heude; Christine Proença; Jacques Veslot; Béatrice Jouret; Jean Tichet; Guillaume Charpentier; Michel Marre; Beverley Balkau; philippe froguel; David Meyre
Secretory granule neuroendocrine protein 1 (SGNE1) genetic variation and glucose intolerance in severe childhood and adult obesity.
BMC medical genetics 2007;8():44.
2006: Stéphane Cauchi; David Meyre; Christian Dina; Hélène Choquet; Chantal Samson; Sophie Gallina; Beverley Balkau; Guillaume Charpentier; François Pattou; Volodymyr Stetsyuk; Raphael Scharfmann; Bart Staels; Gema Frühbeck; philippe froguel
Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
Diabetes 2006;55(10):2903-8.
2006: Guillaume Charpentier; D Dardari; Jean-Pierre Riveline
How should postprandial glycemia be treated?
Diabetes & metabolism 2006;32 Spec No2():2S21-7.
2006: Claire Cheyssac; Christian Dina; frederic lepretre; Valérie Vasseur-Delannoy; Aurélie Dechaume; Stéphane Lobbens; Beverley Balkau; Juan Ruiz; Guillaume Charpentier; François Pattou; Erik Joly; Marc Prentki; Torben Hansen; Oluf Pedersen; Martine Vaxillaire; philippe froguel
EIF4A2 is a positional candidate gene at the 3q27 locus linked to type 2 diabetes in French families.
Diabetes 2006;55(4):1171-6.
2006: Martine Vaxillaire; Aurélie Dechaume; Valérie Vasseur-Delannoy; Saida Lahmidi; Vincent Vatin; frederic lepretre; Philippe Boutin; Serge Hercberg; Guillaume Charpentier; Christian Dina; philippe froguel
Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population.
Diabetes 2006;55(3):856-61.
2006: Claire Cheyssac; Cécile Lecoeur; Aurélie Dechaume; Amina Bibi; Guillaume Charpentier; Beverley Balkau; Michel Marre; philippe froguel; Fernando Gibson; Martine Vaxillaire
Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population.
BMC medical genetics 2006;7():44.
2006: Guillaume Charpentier; Jean-Pierre Riveline; Dured Dardari; Michel Varroud-Vial
Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?
Drugs 2006;66(3):273-86.
2005: Jean-Pierre Riveline; Marie-Christine Vantyghem; C Fermon; C Brunet; Jean-François Gautier; Eric Renard; Guillaume Charpentier
Subcutaneous insulin resistance successfully circumvented on long term by peritoneal insulin delivery from an implantable pump in four diabetic patients.
Diabetes & metabolism 2005;31(5):496-8.
2005: David Meyre; Nabila Bouatia-Naji; Agnès Tounian; Chantal Samson; Cécile Lecoeur; Vincent Vatin; Maya Ghoussaini; Christophe Wachter; Serge Hercberg; Guillaume Charpentier; Wolfgang Patsch; François Pattou; Marie-Aline Charles; Patrick Tounian; Karine Clément; Béatrice Jouret; Jacques Weill; Betty A Maddux; Ira D Goldfine; Andrew J Walley; Philippe Boutin; Christian Dina; philippe froguel
Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes.
Nature genetics 2005;37(8):863-7.
2005: Guillaume Charpentier; F Fleury; Isabelle Dubroca; Laurent Vaur; Pierre Clerson
Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance.
Diabetes & metabolism 2005;31(2):189-95.
2005: Bernadette Neve; Martin E Fernandez Zapico; Vered Ashkenazi-Katalan; Christian Dina; Yasmin H Hamid; Erik Joly; Emmanuel Vaillant; Yamina Benmezroua; Emmanuelle Durand; Nicolas Bakaher; Valérie Delannoy; Martine Vaxillaire; Tiffany Cook; Geesje M Dallinga-Thie; Hans Jansen; Marie-Aline Charles; Karine Clément; Pilar Galan; Serge Hercberg; Nicole Helbecque; Guillaume Charpentier; Marc Prentki; Torben Hansen; Oluf Pedersen; Raul Urrutia; Danielle Melloul; philippe froguel
Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(13):4807-12.
2005: Maya Ghoussaini; David Meyre; Stéphane Lobbens; Guillaume Charpentier; Karine Clément; Marie-Aline Charles; Maïthé Tauber; Jacques Weill; philippe froguel
Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
BMC medical genetics 2005;6():11.
2005: Martine Vaxillaire; Christian Dina; Stéphane Lobbens; Aurélie Dechaume; Valérie Vasseur-Delannoy; Nicole Helbecque; Guillaume Charpentier; philippe froguel
Effect of common polymorphisms in the HNF4alpha promoter on susceptibility to type 2 diabetes in the French Caucasian population.
Diabetologia 2005;48(3):440-4.
2005: Nicolas Danchin; Guillaume Charpentier; François Ledru; Laurent Vaur; Pascal Guéret; Guy Hanania; Didier Blanchard; Jean-Marc LaBlanche; Nathalie Genès; Jean-Pierre Cambou
Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry.
Diabetes/metabolism research and reviews 2005;21(2):143-9.
2004: Guillaume Charpentier; Jean-Pierre Riveline; Marie-Laure Virally
[Optimising the equilibrium of diabetes and atheromatous progression: myth or reality?].
Archives des maladies du coeur et des vaisseaux 2004;97 Spec No 3():17-21.
2004: Pamela J Kaisaki; Marc Delépine; Peng Y Woon; Liam Sebag-Montefiore; Steven P Wilder; Stephan Menzel; Nathalie Vionnet; Evelyne Marion; Jean-Pierre Riveline; Guillaume Charpentier; Stéphane Schurmans; Jonathan C Levy; Mark Lathrop; Martin Farrall; Dominique Gauguier
Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome.
Diabetes 2004;53(7):1900-4.
2004: Michel Varroud-Vial; D Simon; J Attali; I Durand-Zaleski; L Bera; C Attali; C Letondeur; K Strauss; C Petit; Guillaume Charpentier
Improving glycaemic control of patients with Type 2 diabetes in a primary care setting: a French application of the Staged Diabetes Management programme.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(6):592-8.
2004: Pierre-Jean Guillausseau; Danièle Dubois-Laforgue; Pascale Massin; Marie Laloi-Michelin; Christine Bellanné-Chantelot; H Gin; E Bertin; JF Blickle; B Bauduceau; Beatrice Bouhanick; J Cahen-Varsaux; S Casanova; Guillaume Charpentier; P Chedin; C Derrien; A Grimaldi; Bruno Guerci; E Kaloustian; F Lorenzini; A Murat; F Olivier; Michel Paques; Véronique Paquis-Flucklinger; Amélie Tielmans; M Vincenot; Bernard Vialettes; José Timsit
Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD).
Diabetes & metabolism 2004;30(2):181-6.
2004: Franck Mauvais-Jarvis; Eugène Sobngwi; Raphaël Porcher; Jean-Pierre Riveline; Jean-Philippe Kevorkian; Christian Vaisse; Guillaume Charpentier; Pierre-Jean Guillausseau; Patrick Vexiau; Jean-François Gautier
Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance.
Diabetes 2004;53(3):645-53.
2003: Jean-Pierre Riveline; Nicolas Danchin; François Ledru; Michel Varroud-Vial; Guillaume Charpentier
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications.
Diabetes & metabolism 2003;29(3):207-22.
2003: Guillaume Charpentier; Nathalie Genès; Laurent Vaur; Jacques Amar; Pierre Clerson; J P Cambou; Pascal Guéret
Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.
Diabetes & metabolism 2003;29(2 Pt 1):152-8.
2002: Guillaume Charpentier; Nathalie Genès; Laurent Vaur; Pierre Clerson; Jacques Amar; Pascal Guéret; J P Cambou
[Arterial hypertension management in patients with type 2 diabetes].
Archives des maladies du coeur et des vaisseaux 2002;95(7-8):661-5.
2002: Jacques Amar; Nathalie Genès; Laurent Vaur; Guillaume Charpentier; J P Cambou; Pascal Guéret
[Hypertension management in patients with stable coronary disease].
Archives des maladies du coeur et des vaisseaux 2002;95(7-8):657-60.
2001: Michel Varroud-Vial; Guillaume Charpentier; Laurent Vaur; J R Attali; N Balarac; P Cervantes; L Kleinebreil; C Levy-Marchal; P Preiss; C Weisselberg; E Eschwege
Effects of clinical audit on the quality of care in patients with type 2 diabetes: results of the DIABEST pilot study.
Diabetes & metabolism 2001;27(6):666-74.
2001: Jean-Pierre Riveline; J Capeau; J J Robert; Michel Varroud-Vial; I Cerf-Baron; A Deburge; Guillaume Charpentier
Extreme subcutaneous insulin resistance successfully treated by an implantable pump.
Diabetes care 2001;24(12):2155-6.
2001: Guillaume Charpentier; Laurent Vaur; S Halimi; F Fleury; E Derobert; A Grimaldi; V Oriol; Sylvie Etienne; J J Altman
Predictors of response to glimepiride in patients with type 2 diabetes mellitus.
Diabetes & metabolism 2001;27(5 Pt 1):563-71.
2001: Guillaume Charpentier; F Fleury; M Kabir; Laurent Vaur; S Halimi
Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 2001;18(10):828-34.
2000: Guillaume Charpentier; Jean-Pierre Riveline; H Lardoux; E Mathieu; E Requeda; Michel Varroud-Vial
[Silent ischemic cardiopathy: which diabetics to examine?].
Archives des maladies du coeur et des vaisseaux 2000;93 Spec No 4():25-32.
2000: Guillaume Charpentier; Jean-Pierre Riveline; Michel Varroud-Vial
Management of drugs affecting blood glucose in diabetic patients with renal failure.
Diabetes & metabolism 2000;26 Suppl 4():73-85.
2000: Karine Clement; Serge Hercberg; B Passinge; P Galan; Michel Varroud-Vial; Alan R Shuldiner; Brock A Beamer; Guillaume Charpentier; Bernard Guy-Grand; philippe froguel; Christian Vaisse
The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(3):391-3.
1999: Michel Varroud-Vial; P Mechaly; S Joannidis; O Chapiro; S Pichard; A Lebigot; M Moulonguet; C Attali; A Bayle; J Bénier; Guillaume Charpentier
Cooperation between general practitioners and diabetologists and clinical audit improve the management of type 2 diabetic patients.
Diabetes & metabolism 1999;25(1):55-63.
1998: Jean-Claude Chèvre; El Habib Hani; Philippe Boutin; Martine Vaxillaire; Hélène Blanché; Nathalie Vionnet; Victor Cavalcanti Pardini; José Timsit; Etienne Larger; Guillaume Charpentier; D Beckers; M Maes; Christine Bellanné-Chantelot; Gilberto Velho; philippe froguel
Mutation screening in 18 Caucasian families suggest the existence of other MODY genes.
Diabetologia 1998;41(9):1017-23.
1997: Martine Vaxillaire; M Rouard; K Yamagata; Naohisa Oda; Pamela J Kaisaki; V V Boriraj; J C Chevre; V Boccio; R D Cox; G Mark Lathrop; P Dussoix; Jacques Philippe; José Timsit; Guillaume Charpentier; Gilberto Velho; Graeme I Bell; philippe froguel
Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3).
Human molecular genetics 1997;6(4):583-6.
1996: Gilberto Velho; Martine Vaxillaire; V Boccio; Guillaume Charpentier; philippe froguel
Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q.
Diabetes care 1996;19(9):915-9.
1995: J Ruiz; Hélène Blanché; Richard W James; M C Garin; C Vaisse; Guillaume Charpentier; N Cohen; A Morabia; Philippe Passa; philippe froguel
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.
Lancet 1995;346(8979):869-72.